Literature DB >> 25253949

Current treatment options for colon cancer peritoneal carcinomatosis.

Tomoyoshi Aoyagi1, Krista P Terracina1, Ali Raza1, Kazuaki Takabe1.   

Abstract

Peritoneal carcinomatosis (PC), the dissemination of cancer cells throughout the lining of the abdominal cavity, is the second most common presentation of colon cancer distant metastasis. Despite remarkable advances in cytotoxic chemotherapy and targeted therapy for colon cancer over the last 15 years, it has been repeatedly shown that these therapies remain ineffective for colon cancer PC. Recently, there has been a rapid accumulation of reports that cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) prolongs the life of colon cancer PC patients. Here, we will review the clinical presentation, the mechanisms of disease progression, and current treatment options for colon cancer PC, with a focus on the benefits and limitations of CRS-HIPEC.

Entities:  

Keywords:  Cancer; Carcinomatosis; Colorectal; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal chemotherapy; Mechanism; Peritoneal

Mesh：

Substances：

Year:  2014        PMID： 25253949      PMCID： PMC4168082          DOI： 10.3748/wjg.v20.i35.12493

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  80 in total

1.  Surgical management of colorectal lung metastasis.

Authors:  P James Villeneuve; R Sudhir Sundaresan
Journal:  Clin Colon Rectal Surg       Date:  2009-11

2.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.

Authors:  Michael G House; Hiromichi Ito; Mithat Gönen; Yuman Fong; Peter J Allen; Ronald P DeMatteo; Murray F Brennan; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

3.  Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer.

Authors:  Wen-Hua Li; Jun-Jie Peng; Jia-Qing Xiang; Wei Chen; San-Jun Cai; Wen Zhang
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

4.  Pathophysiology and biology of peritoneal carcinomatosis.

Authors:  Shigeki Kusamura; Dario Baratti; Nadia Zaffaroni; Raffaella Villa; Barbara Laterza; Maria Rosaria Balestra; Marcello Deraco
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

5.  Long-term survival of peritoneal carcinomatosis of colorectal origin.

Authors:  Vic J Verwaal; Serge van Ruth; Arjen Witkamp; Henk Boot; Gooike van Slooten; Frans A N Zoetmulder
Journal:  Ann Surg Oncol       Date:  2004-12-27       Impact factor: 5.344

6.  Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.

Authors:  Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven Alberts
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

7.  Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.

Authors:  S A Cannistra; G S Kansas; J Niloff; B DeFranzo; Y Kim; C Ottensmeier
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  P H Sugarbaker; K A Jablonski
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

10.  Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction.

Authors:  R M Heath; D G Jayne; R O'Leary; E E Morrison; P J Guillou
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
View more
  30 in total

Review 1.  [Prognostic biomarkers for metastatic colorectal cancer].

Authors:  J H L Neumann
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

2.  PIPAC puts pressure on peritoneal metastases from pancreatic cancer.

Authors:  Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2017-06       Impact factor: 5.150

Review 3.  Abdominal metastases from colorectal cancer: intraperitoneal therapy.

Authors:  Hamza Guend; Sunil Patel; Garrett M Nash
Journal:  J Gastrointest Oncol       Date:  2015-12

4.  Localized peritoneal carcinomatosis mimicking an irreducible left inguinal hernia.

Authors:  N C Buchs; A L A Bloemendaal; R J Guy
Journal:  Ann R Coll Surg Engl       Date:  2016-03       Impact factor: 1.891

5.  ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer.

Authors:  Corrado Pedrazzani; Giulia Turri; Gyu Seog Choi
Journal:  Ann Surg Oncol       Date:  2022-07-12       Impact factor: 4.339

6.  Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis.

Authors:  Hiroaki Aoki; Masayo Aoki; Eriko Katsuta; Rajesh Ramanathan; Michael O Idowu; Sarah Spiegel; Kazuaki Takabe
Journal:  J Surg Res       Date:  2016-07-09       Impact factor: 2.192

7.  Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.

Authors:  Caroline Theresa Seebauer; Stefan Brunner; Gabriel Glockzin; Pompiliu Piso; Petra Ruemmele; Hans-Juergen Schlitt; Edward Kenneth Geissler; Stefan Fichtner-Feigl; Rebecca Kesselring
Journal:  Oncoimmunology       Date:  2016-10-14       Impact factor: 8.110

8.  In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth.

Authors:  Michael Bordonaro; Senji Shirasawa; Darina L Lazarova
Journal:  Cancers (Basel)       Date:  2016-05-14       Impact factor: 6.639

Review 9.  Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum.

Authors:  Lieselotte Lemoine; Paul Sugarbaker; Kurt Van der Speeten
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

10.  Colorectal cancer-promoting activity of the senescent peritoneal mesothelium.

Authors:  Justyna Mikuła-Pietrasik; Patrycja Sosińska; Konstantin Maksin; Mał Gorzata Kucińska; Hanna Piotrowska; Marek Murias; Aldona Woźniak; Dariusz Szpurek; Krzysztof Książek
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.